npj Precision Oncology

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

NPJ PRECIS ONCOL

ISSN / eISSN

2397-768X / 2397-768X

目标和范围

npj Precision Oncology is an international, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications to clinical medicine.

研究方向

肿瘤学

CiteScore

9.60

查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - Oncology	Q1	#53/366
Medicine - Cancer Research	Q1	#48/214

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
ONCOLOGY - SCIE	Q1

出版国家或地区

ENGLAND

出版商

Springer Nature

出版年份

2017

年文章数

Open Access

YES

通讯方式

HEIDELBERGER PLATZ 3, BERLIN, GERMANY, 14197

同领域相关热门期刊
近期发表文章

Biology-aware mutation-based deep learning for outcome prediction of cancer immunotherapy with immune checkpoint inhibitors: (2023) Junyan Liu, Md Tauhidul Islam, Shengtian Sang, Liang Qiu, Lei Xing

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution: (2023) Jaime L. Schneider, Khvaramze Shaverdashvili, Mari Mino-Kenudson, Subba R. Digumarthy, Andrew Do, Audrey Liu, Justin F. Gainor, Jochen K. Lennerz, Tim...

In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy: (2023) Sara Corvigno, Sunil Badal, Meredith L. Spradlin, Michael Keating, Igor Pereira, Elaine Stur, Emine Bayraktar, Katherine I. Foster, Nicholas W. Batema...

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer: (2023) Michele Garioni, Viviane J. Tschan, Lauriane Blukacz, Sandro Nuciforo, Romuald Parmentier, Luca Roma, Mairene Coto-Llerena, Heike Pueschel, Salvatore...

Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases: (2023) Francesca Khani, William F. Hooper, Xiaofei Wang, Timothy R. Chu, Minita Shah, Lara Winterkorn, Michael Sigouros, Vincenza Conteduca, David Pisapia, S...

Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma: (2023) Jun Wang, Na Sun, Thomas Kunzke, Jian Shen, Philipp Zens, Verena M. Prade, Annette Feuchtinger, Sabina Berezowska, Axel Walch

Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma: (2023) Juan Feng, Yang Lan, Feng Liu, Ye Yuan, Jia Ge, Sen Wei, Hu Luo, Jianjun Li, Tao Luo, Xiuwu Bian

The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients: (2023) Emma Åkerlund, Greta Gudoityte, Elisabeth Moussaud-Lamodière, Olina Lind, Henri Colyn Bwanika, Kaisa Lehti, Sahar Salehi, Joseph Carlson, Emelie Walli...

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology: (2023) Andreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, Christoph E. Heilig, Jennifer Hüllein, Lino Möhrmann, Arne Jahn, Dorothea Hanf, Irina A. Kerl...

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes: (2023) Koh Furugaki, Takaaki Fujimura, Hayato Mizuta, Takuya Yoshimoto, Takashi Asakawa, Yasushi Yoshimura, Shigeki Yoshiura

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

Does anyone know how long the initial review of this magazine usually takes? It has been over ten days since I submitted it, but it is still in the submission status. It feels like it's on hold or something.

2022-05-27

I want to know, how long does this magazine usually take to reject submissions? I submitted my manuscript, but it has been in the "manuscript received" status for days.

2023-02-20

查看所有评论

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now